本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sutro Biopharma Inc

20.49
-0.5500-2.61%
盘后20.490.00000.00%16:20 EDT
成交量:27.51万
成交额:559.14万
市值:3.39亿
市盈率:-1.18
高:21.51
开:21.49
低:19.55
收:21.04
52周最高:43.85
52周最低:7.15
股本:1,656.72万
流通股本:1,076.62万
量比:1.01
换手率:2.56%
股息:- -
股息率:- -
每股收益(TTM):-17.3700
每股收益(LYR):-22.4900
净资产收益率:-1810.01%
总资产收益率:-36.08%
市净率:-3.29
市盈率(LYR):-0.91

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/08

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/21

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/21

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/31

SEC问询函

Form CORRESP - Correspondence
2026/03/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/23

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/23

重要事件披露

Form 8-K - Current report
2026/02/10

重要事件披露

Form 8-K - Current report
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities